Abstract
INTRODUCTION
Prostate cancer is a prostate gland malignant tumor suffering men over 50 year in which 75% were found in 80 year old men and 30% in 70 year old men [1] . Prosate cancer was the second most malignancy in men after lung cancer [2] . In 2004 in The United States of America 230.110 prostate cancer patients were found. Prostate cancer was often found in AfroAmerica and the black skin was more than the white one [1] . Prostate cancer in Indonesia was the the most malignancy in urology clinic and 2006-2010 there were 971 cases [4] . A study by Yuwinanda (2008) din Arifin Achmad Regional General Hospital Pekanbaru Riau Province, prostat cancer was the third malignancy of 12 malignancies in urology [4] .
High incidence of prostate cancer cases in Indonesia indicated the demand of diagnostic and prognostic parameters of prostate cancer such as yaitu Prostate Specific Antigent (PSA) (5) . PSA is a marker of malignancy process correlating positively to prostate cancer [6] . PSA role in prostate enlargement is improving sel tumor cell proliferation through the function as coactivator for increasing Androgen Reseptor (AR) in which highly influencing on the prostate growth. The increase of serum PSA level has become an important marker of several prostat diseases is not only found in prostate cancer but can also found in Benign Prostate Hyperplasia (BPH) [7] .
Benign Prostate Hyperplasia is a prostate enlargement in which can cause posterior urethral narrowing adalah penyakit pembesaran prostat yang dapat menyebabkan penyempitan urethra posterior [1] . Although it seldom cause life threatening, BPH symptoms result in disturbance of daily activities, and the prostate enlargement process occurs slowly. Transurethral Resection of the Prostate (TURP) is a most effective and gold standart management of indicated BPH [8] . The success rate of TURP in overcoming the clinical symptoms due to BPH was 88% [9] .
Many studies on PSA levels of prostate before TURP had been published. Study on normal digital rectal and normal PSA level in clinical BPH patients underwent and in fact the histopathology findings were prostate cancer had been published yet. That was why, according to the above data we aimed to conduct a study on evaluating the prediction of prostate cancer based on and normal PSA) in clinical Benign Prostate Hyperplasia.
MATERIALS AND METHODS
We reviewed medical records of prostate cancer in prostate enlargement patients with urinary retension underwent TURP based on normal DRE, and normal PSA in Arifin Achmad Regional General Hospital, Pekanbaru, Riau Province, Indonesia in January 2010 -Desember 2016. Statistical analysis of univariate was used. Approval on the study was 
RESULT
There were 644 prostate enlargement with urinary retension patients underwent TURP in Arifin Achmad Regional General Hospital, Pekanbaru, Riau Province fulfilled the inclusion criteria during seven year in January 2010 -December 2016.
DISCUSSION
There were 644 prostate enlargement with urinary retension patients underwent TURP in Arifin Achmad Regional General Hospital, Pekanbaru, Riau Province fulfilled the inclusion criteria during seven year in January 2010 -December 2016. This study showed that the most age group of prostate enlargement cases with urinary retension was 60-69 year namely 21 (50%) patients while the less one were 40-49 year and ≥ 80 year namely 31 (4.8%) patient (See in Table 1 ). Some studies PCa occurred in younger patients (< 60 years) and to dissipate in older groups (>70 years) This study showed DRE findings in prostate enlargement patients with urinary retension before TURP were mostly normal namely 441 (69.7%) patients while the less one abnormal namely 197 (30.6%) patients (See in Table 2 ). This study showed that in prostate enlargement patients with urinary retension before TURP, PSA levels were mostly 4.1 -10 ng/ml namely 291 (45.2%) patients followed by > 20 ng/ml namely 184 (28.6%) patients and ≤ 4 ng/ml namly 122 (19%) pasien (See in Table 3 ). 
Total 644 100
This study showed histopathology findings in prostate enlargement patients with urinary retension underwent TURP were mostly BPH namely 541 (84%) patients while PCa were 103 (16%) patients (See in Table 4 ). 
This study showed bone scan findings in in prostate enlargement patients with urinary retension underwent TURP were mostly negative metastasis namely 59 (57.3%) patients while positive metastasis namely 44 (47.7) patients (See in Table 5 ). Table 6 ). Table 7 ). This prediction was higher than the one of a study by Thomson (2004) namely 15.2% [11] . 
Jumlah 103 100
This study showed PCa stages in clinical BPH without signs of PCa in prostate enlargement patients with urinary retension underwent TURP were PCa which were clinical PCa before TURP mostly the advanced stage namely 15 (79%) patients while PCa which were clinical BPH before TURP were lesser namely local stage in 4 (21%) patients (See in Table 8 ). Table 9 ). Table 10 ). 
